News and Trends 21 Jun 2023
FDA clears T-Cell receptor natural killer cell therapy for sarcoma
Replay, a genome writing company, and The University of Texas MD Anderson Cancer Center (MD Anderson), have announced that the U.S. Food & Drug Administration (FDA) has issued a ‘safe…